There are no exact figures for the recurrence rate of the mixed cell type of classical Hodgkin’s lymphoma. Hodgkin’s lymphoma is a tumor derived from monoclonal B-cells, including classic Hodgkin’s lymphoma, of which the mixed cell type is a subtype. Effective cure can usually be achieved through radiotherapy, chemotherapy, targeted therapy, immunotherapy, and hematopoietic stem cell transplantation therapy, and the cure rate is usually 60% to 80%. Drugs include adriamycin, bleomycin, vincristine, dacarbazine, and PD-1 monoclonal antibody, etc. Its prognosis is generally related to age, gender, type of tumor, and clinical manifestations. Patients are advised to receive standardized treatment in regular hospitals, and also need to go to the hospital for regular review after achieving complete remission.